J. Munjal
Jewish Hospital
5 Papers
65 Citations
J. Munjal is an academic researcher from Jewish Hospital. The author has contributed to research in topics: Factor V Leiden & Thrombophilia. The author has an hindex of 5, co-authored 5 publications.
Chat about Author
Papers
Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies
Charles J. Glueck,Dawit Aregawi,M. Agloria,Qasim Khalil,M. Winiarska,J. Munjal,Srikanth Gogineni,Ping Wang +7 more
TL;DR: In these 61 hypercholesterolemic patients unable to tolerate other statins and, subsequently in some cases, unable to meet LDL-C goals while receiving nonstatin LIT monotherapy, preliminary observations suggest that rosuvastatin at doses of 5 and 10 mg/d+diet was well tolerated, effective, and had a good safety profile.
81
Factor V Leiden mutation: a treatable etiology for sporadic and recurrent pregnancy loss.
TL;DR: After unexplained sporadic pregnancy loss, as well as after RPL, to provide the option to prospectively optimize subsequent live birth outcomes with low-molecular-weight heparin thromboprophylaxis, it is suggested that measurements be done of the FVL mutation, a treatable etiology for sporadicregnancy loss aswell as for RPL.
37
Endothelial nitric oxide synthase T-786C mutation, a reversible etiology of Prinzmetal's angina pectoris.
TL;DR: The eNOS T-786C mutation appears to be a reversible etiology of Prinzmetal's variant angina in white Americans whose angina might be ameliorated by l-arginine.
23
Thrombophilia-hypofibrinolysis and atherothrombotic cardiovascular disease ≤ age 45 years
Charles J. Glueck,J. Munjal,Dawit Aregawi,Maliha Agloria,M. Winiarska,Qasim Khalil,Ping Wang +6 more
TL;DR: In patients with ATCVD < or = age 45 years, thrombophilias (Factor V Leiden, Factor VIII, Factor XI, protein C and S deficiency, lupus anticoagulant) and hypofibrinolysis (PAI-Fx, Lp) may promote arterial thromBosis, which is synergistic with atherosclerotic endothelial injury.
22
74 metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome.
TL;DR: In adolescents with PCOS, metformin-diet reduces weight, insulin, IR, cholesterol, and triglycerides and facilitates resumption of regular menses and the importance of the earliest diagnosis and treatment of PCOS in adolescence lies in primary prevention of adult endocrinopathy, obesity, infertility, hyperinsulinemia, hypertriglyceridemia, type 2 diabetes, and increased cardiovascular morbidity-mortality.
9